$0.2272
-0.00283-1.23%
Pre-Market: 7:31 PM EDT
Comments
Loading...
Adaptimmune Therapeutics Insider Trading Activity | NASDAQ:ADAP | Benzinga
Track the latest Adaptimmune Therapeutics insider trading activity. Stay informed on recent buys, sells, and market impact for Adaptimmune Therapeutics stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Adaptimmune Therapeutics PLC Insiders Doing?
Insiders have report no purchases/sales in the last 30 days.
Notable Recent Insider Buys and Sales
- On January 17, 2025, Elliot Norry, the company's CHIEF MEDICAL OFFICER sold 5.58K shares for $0.58 each.
- On January 17, 2025, John Lunger, the company's CHIEF PATIENT SUPPLY OFFICER sold 5.58K shares for $0.58 each.
- On January 17, 2025, William Charles Bertrand, the company's CHIEF OPERATING OFFICER sold 5.58K shares for $0.58 each.
Ownership Statistics for Adaptimmune Therapeutics PLC
Shares Outstanding
257.232M
Insider Shares Owned
31.313M
Insider Percentage Owned
2.04%
Institutional Shares Held
12.125M
Institutional Percentage Held
4.74%
| Jan 17, 2025 | Elliot Norry | CHIEF MEDICAL OFFICER | -5.58K | $0.58 | -$3.24K | SELL | -42.65% | 7.51K | Jan 17 | View |
| Jan 17, 2025 | John Lunger | CHIEF PATIENT SUPPLY OFFICER | -5.58K | $0.58 | -$3.24K | SELL | -42.65% | 7.51K | Jan 17 | View |
| Jan 17, 2025 | William Charles Bertrand | CHIEF OPERATING OFFICER | -5.58K | $0.58 | -$3.24K | SELL | -42.65% | 7.51K | Jan 17 | View |
| Jan 17, 2025 | Adrian Rawcliffe | CHIEF EXECUTIVE OFFICER | -30.60K | $0.58 | -$17.77K | SELL | -40.84% | 44.33K | Jan 17 | View |
| Jan 15, 2025 | Adrian Rawcliffe | CHIEF EXECUTIVE OFFICER | -59.57K | $0.58 | -$34.64K | SELL | -58.89% | 41.58K | Jan 13 - Jan 15 | View |
| Jan 15, 2025 | Cintia Piccina | CHIEF COMMERCIAL OFFICER | -12.99K | $0.57 | -$7.47K | SELL | -41.36% | 18.42K | Jan 15 | View |
| Jan 15, 2025 | Elliot Norry | CHIEF MEDICAL OFFICER | -22.20K | $0.58 | -$12.92K | SELL | -61.74% | 13.76K | Jan 13 - Jan 15 | View |
| Jan 15, 2025 | John Lunger | CHIEF PATIENT SUPPLY OFFICER | -19.54K | $0.58 | -$11.36K | SELL | -58.69% | 13.76K | Jan 13 - Jan 15 | View |
| Jan 15, 2025 | William Charles Bertrand | CHIEF OPERATING OFFICER | -19.54K | $0.58 | -$11.36K | SELL | -58.69% | 13.76K | Jan 13 - Jan 15 | View |
| Jun 18, 2024 | Cintia Piccina | CHIEF COMMERCIAL OFFICER | -24.53K | $0.93 | -$22.81K | SELL | -39.05% | 38.29K | Jun 18 | View |
| Jan 17, 2024 | Adrian Rawcliffe | CHIEF EXECUTIVE OFFICER | -39.38K | $0.70 | -$27.59K | SELL | -46.76% | 44.85K | Jan 16 - Jan 17 | View |
| Jan 17, 2024 | Elliot Norry | CHIEF MEDICAL OFFICER | -20.56K | $0.69 | -$14.11K | SELL | -51.64% | 19.26K | Jan 16 - Jan 17 | View |
| Jan 17, 2024 | John Lunger | CHIEF PATIENT SUPPLY OFFICER | -22.80K | $0.70 | -$15.89K | SELL | -54.52% | 19.02K | Jan 16 - Jan 17 | View |
| Jan 17, 2024 | William Charles Bertrand | CHIEF OPERATING OFFICER | -23.59K | $0.70 | -$16.42K | SELL | -53.87% | 20.20K | Jan 16 - Jan 17 | View |
| Jan 12, 2024 | Elliot Norry | CHIEF MEDICAL OFFICER | -11.81K | $0.85 | -$10.02K | SELL | -49.93% | 11.84K | Jan 11 - Jan 12 | View |
| Jan 12, 2024 | William Charles Bertrand | CHIEF OPERATING OFFICER | -9.23K | $0.85 | -$7.81K | SELL | -53.96% | 7.87K | Jan 11 - Jan 12 | View |
| Jan 12, 2024 | Adrian Rawcliffe | CHIEF EXECUTIVE OFFICER | -29.20K | $0.85 | -$24.73K | SELL | -52.53% | 26.39K | Jan 11 - Jan 12 | View |
| Jan 12, 2024 | John Lunger | CHIEF PATIENT SUPPLY OFFICER | -9.23K | $0.85 | -$7.81K | SELL | -53.96% | 7.87K | Jan 11 - Jan 12 | View |
| Sep 01, 2023 | Adrian Rawcliffe | CHIEF EXECUTIVE OFFICER | -2.40K | $0.78 | -$1.87K | SELL | -41.06% | 3.45K | Sep 01 | View |
| Aug 01, 2023 | John Lunger | CHIEF PATIENT SUPPLY OFFICER | -3.10K | $0.91 | -$2.80K | SELL | -39.62% | 4.72K | Aug 01 | View |
| Jul 10, 2023 | Garry E Menzel | DIRECTOR | -47.70K | $0.91 | -$43.45K | SELL | -38.86% | 75.06K | Jul 10 | View |
| Jun 27, 2023 | Adrian Rawcliffe | CHIEF EXECUTIVE OFFICER | -2.33K | $0.92 | -$2.15K | SELL | -39.87% | 3.52K | Jun 27 | View |
| Jan 31, 2023 | Cintia Piccina | CHIEF COMMERCIAL OFFICER | -11.89K | $1.87 | -$22.23K | SELL | -37.84% | 19.54K | Jan 31 | View |
| Jan 17, 2023 | John Lunger | CHIEF PATIENT SUPPLY OFFICER | -4.44K | $1.86 | -$8.25K | SELL | -37.94% | 7.26K | Jan 17 | View |
| Jan 17, 2023 | William Charles Bertrand | CHIEF OPERATING OFFICER | -4.44K | $1.86 | -$8.25K | SELL | -37.94% | 7.26K | Jan 17 | View |
| Jan 17, 2023 | Elliot Norry | CHIEF MEDICAL OFFICER | -2.16K | $1.86 | -$4.01K | SELL | -38.21% | 3.49K | Jan 17 | View |
| Jan 17, 2023 | Adrian Rawcliffe | CHIEF EXECUTIVE OFFICER | -10.06K | $1.86 | -$18.69K | SELL | -42.96% | 13.35K | Jan 17 | View |
| Jan 12, 2023 | William Charles Bertrand | CHIEF OPERATING OFFICER | -8.82K | $1.72 | -$15.20K | SELL | -52.05% | 8.12K | Jan 11 - Jan 12 | View |
| Jan 12, 2023 | John Lunger | CHIEF PATIENT SUPPLY OFFICER | -8.82K | $1.72 | -$15.20K | SELL | -52.05% | 8.12K | Jan 11 - Jan 12 | View |
| Jan 12, 2023 | Elliot Norry | CHIEF MEDICAL OFFICER | -11.29K | $1.72 | -$19.42K | SELL | -48.09% | 12.19K | Jan 11 - Jan 12 | View |
| Jan 12, 2023 | Adrian Rawcliffe | CHIEF EXECUTIVE OFFICER | -31.80K | $1.72 | -$54.79K | SELL | -56.11% | 24.88K | Jan 11 - Jan 12 | View |
| Jan 04, 2023 | William Charles Bertrand | CHIEF OPERATING OFFICER | -3.58K | $1.69 | -$6.07K | SELL | -38.27% | 5.78K | Jan 04 | View |
| Jan 04, 2023 | John Lunger | CHIEF PATIENT SUPPLY OFFICER | -1.10K | $1.69 | -$1.86K | SELL | -38.94% | 1.73K | Jan 04 | View |
| Jan 04, 2023 | Elliot Norry | CHIEF MEDICAL OFFICER | -876.00 | $1.69 | -$1.48K | SELL | -39.16% | 1.36K | Jan 04 | View |
| Jan 04, 2023 | Adrian Rawcliffe | CHIEF EXECUTIVE OFFICER | -5.07K | $1.69 | -$8.59K | SELL | -43.34% | 6.63K | Jan 04 | View |
| Sep 01, 2022 | Adrian Rawcliffe | CHIEF EXECUTIVE OFFICER | -2.54K | $1.97 | -$4.99K | SELL | -43.34% | 3.32K | Sep 01 | View |
| Aug 01, 2022 | John Lunger | CHIEF PATIENT SUPPLY OFFICER | -2.98K | $1.77 | -$5.29K | SELL | -38.18% | 4.83K | Aug 01 | View |
| Aug 01, 2022 | Cintia Piccina | CHIEF COMMERCIAL OFFICER | -21.04K | $1.77 | -$37.31K | SELL | -37.66% | 34.82K | Aug 01 | View |
| Jul 05, 2022 | John Lunger | CHIEF PATIENT SUPPLY OFFICER | -1.97K | $1.68 | -$3.31K | SELL | -38.86% | 3.10K | Jul 05 | View |
| Jun 27, 2022 | Adrian Rawcliffe | CHIEF EXECUTIVE OFFICER | -2.56K | $1.63 | -$4.18K | SELL | -43.78% | 3.29K | Jun 27 | View |
| May 23, 2022 | Gavin Wood | CHIEF FINANCIAL OFFICER | 39.00K | $0.29 | $11.33K | BUY | 68.42% | 96.00K | May 20 | View |
| Jan 18, 2022 | William Charles Bertrand | CHIEF OPERATING OFFICER | -4.37K | $3.19 | -$13.94K | SELL | -37.32% | 7.34K | Jan 18 | View |
| Jan 18, 2022 | John Lunger | CHIEF PATIENT SUPPLY OFFICER | -4.37K | $3.19 | -$13.94K | SELL | -37.32% | 7.34K | Jan 18 | View |
| Jan 18, 2022 | Elliot Norry | CHIEF MEDICAL OFFICER | -2.12K | $3.19 | -$6.77K | SELL | -37.54% | 3.53K | Jan 18 | View |
| Jan 18, 2022 | Adrian Rawcliffe | CHIEF EXECUTIVE OFFICER | -11.10K | $3.19 | -$35.42K | SELL | -47.40% | 12.31K | Jan 18 | View |
| Jan 13, 2022 | William Charles Bertrand | CHIEF OPERATING OFFICER | -6.02K | $3.55 | -$21.38K | SELL | -61.58% | 3.75K | Jan 11 - Jan 12 | View |
| Jan 13, 2022 | John Lunger | CHIEF PATIENT SUPPLY OFFICER | -4.85K | $3.55 | -$17.22K | SELL | -73.48% | 1.75K | Jan 11 - Jan 12 | View |
| Jan 13, 2022 | Elliot Norry | CHIEF MEDICAL OFFICER | -4.62K | $3.55 | -$16.44K | SELL | -76.98% | 1.38K | Jan 11 - Jan 12 | View |
| Jan 13, 2022 | Adrian Rawcliffe | CHIEF EXECUTIVE OFFICER | -17.41K | $3.55 | -$61.88K | SELL | -83.84% | 3.36K | Jan 11 - Jan 12 | View |
| Jan 05, 2022 | William Charles Bertrand | CHIEF OPERATING OFFICER | -3.49K | $4.06 | -$14.18K | SELL | -37.27% | 5.87K | Jan 04 | View |
| Jan 05, 2022 | John Lunger | CHIEF PATIENT SUPPLY OFFICER | -1.07K | $4.06 | -$4.35K | SELL | -37.88% | 1.75K | Jan 04 | View |
| Jan 05, 2022 | Elliot Norry | CHIEF MEDICAL OFFICER | -849.00 | $4.06 | -$3.45K | SELL | -37.95% | 1.39K | Jan 04 | View |
| Jan 05, 2022 | Adrian Rawcliffe | CHIEF EXECUTIVE OFFICER | -5.53K | $4.06 | -$22.48K | SELL | -47.27% | 6.17K | Jan 04 | View |
| Aug 02, 2021 | John Lunger | CHIEF PATIENT SUPPLY OFFICER | -2.94K | $3.58 | -$10.54K | SELL | -37.62% | 4.87K | Aug 02 | View |
| Jul 02, 2021 | William Charles Bertrand | CHIEF OPERATING OFFICER | -4.38K | $4.26 | -$18.66K | SELL | -37.38% | 7.33K | Jul 02 | View |
| Jul 02, 2021 | John Lunger | CHIEF PATIENT SUPPLY OFFICER | -1.91K | $4.26 | -$8.13K | SELL | -37.56% | 3.17K | Jul 02 | View |
| Jun 28, 2021 | Adrian Rawcliffe | CHIEF EXECUTIVE OFFICER | -2.79K | $4.37 | -$12.21K | SELL | -47.74% | 3.06K | Jun 28 | View |
| Jun 03, 2021 | Lawrence M Alleva | DIRECTOR | 12.60K | $0.79 | $9.95K | BUY | 17.85% | 83.18K | Jun 01 | View |
| Jan 19, 2021 | Elliot Norry | CHIEF MEDICAL OFFICER | -2.11K | $5.67 | -$11.97K | SELL | -37.36% | 3.54K | Jan 19 | View |
| Jan 19, 2021 | John Lunger | CHIEF PATIENT SUPPLY OFFICER | -4.36K | $5.67 | -$24.71K | SELL | -37.24% | 7.35K | Jan 19 | View |
| Jan 19, 2021 | Adrian Rawcliffe | CHIEF EXECUTIVE OFFICER | -9.88K | $5.67 | -$56.01K | SELL | -42.20% | 13.53K | Jan 19 | View |
| Jan 12, 2021 | William Charles Bertrand | CHIEF OPERATING OFFICER | -2.23K | $6.15 | -$13.74K | SELL | -37.22% | 3.77K | Jan 12 | View |
| Jan 12, 2021 | John Lunger | CHIEF PATIENT SUPPLY OFFICER | -1.06K | $6.15 | -$6.51K | SELL | -37.45% | 1.77K | Jan 12 | View |
| Jan 12, 2021 | Elliot Norry | CHIEF MEDICAL OFFICER | -841.00 | $6.15 | -$5.17K | SELL | -37.59% | 1.40K | Jan 12 | View |
| Jan 12, 2021 | Adrian Rawcliffe | CHIEF EXECUTIVE OFFICER | -2.71K | $6.15 | -$16.65K | SELL | -42.28% | 3.69K | Jan 12 | View |
| Jan 05, 2021 | John Lunger | CHIEF PATIENT SUPPLY OFFICER | -1.06K | $5.33 | -$5.67K | SELL | -37.70% | 1.76K | Jan 04 | View |
| Jan 05, 2021 | William Charles Bertrand | CHIEF OPERATING OFFICER | -3.50K | $5.33 | -$18.64K | SELL | -37.37% | 5.86K | Jan 04 | View |
| Jan 05, 2021 | Elliot Norry | CHIEF MEDICAL OFFICER | -845.00 | $5.33 | -$4.50K | SELL | -37.77% | 1.39K | Jan 04 | View |
| Jan 05, 2021 | Adrian Rawcliffe | CHIEF EXECUTIVE OFFICER | -4.97K | $5.33 | -$26.46K | SELL | -42.44% | 6.74K | Jan 04 | View |
| Dec 16, 2020 | Gavin Wood | — | 24.00K | $0.69 | $16.55K | PURCHASE | 72.73% | 57.00K | Dec 14 | View |
| Dec 15, 2020 | William Bertrand | — | 207.00K | $0.69 | $143.82K | PURCHASE | 266.04% | 284.81K | Dec 14 | View |
| Sep 02, 2020 | Adrian Rawcliffe | — | -2.78K | $8.51 | -$23.64K | SELL | -47.44% | 3.08K | Sep 01 | View |
| Aug 04, 2020 | John Lunger | — | -4.82K | $9.25 | -$44.61K | SELL | -37.42% | 8.07K | Aug 03 | View |
| Aug 04, 2020 | KATRINA HELEN TAYTONMARTIN | — | -200.00K | $8.74 | -$1.75M | SELL | -100.00% | 0.00 | Aug 03 | View |
| Aug 04, 2020 | Adrian Rawcliffe | — | -2.79K | $9.25 | -$25.79K | SELL | -47.64% | 3.06K | Aug 03 | View |
| Jun 30, 2020 | Gavin Wood | — | 33.00K | $1.62 | $53.46K | PURCHASE | ∞ | 33.00K | Jun 29 | View |
| Jun 11, 2020 | Lawrence M Alleva | — | 12.90K | $1.89 | $24.38K | PURCHASE | 18.28% | 83.48K | Jun 09 | View |
| Jun 02, 2020 | James Noble | — | -500.00K | $9.33 | -$4.67M | SELL | -100.00% | 0.00 | May 29 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.